Elevation Oncology LLC
ELEV · NASDAQ
Price unavailable right now.
No price history for this range.
About ELEV
- Employees
- 34
- Headquarters
- Boston, Massachusetts
- Listed
- Jun 25, 2021
- Sector
- Health Care
- Industry
- Biotechnology
- Website
- elevationoncology.com
Leadership
| Name | Title | Since |
|---|---|---|
| Kevin Tang | — | 2025 |
| Michael Hearne | — | — |
| Ryan Cole | — | — |
| Stew Kroll | — | — |
| Thomas Wei | — | — |
Suppliers and customers
Price correlation is over one year: 1 means the stocks move together, -1 opposite
| Company | Relationship | Correlation |
|---|---|---|
| Ligand Pharmaceuticals LGND | Supplier and customer | — |
| NeoGenomics NEO | Supplier and customer | — |
| EXACT Sciences EXAS | Supplier and customer | — |
| McKesson MCK | Supplier and customer | — |
| Caris Life Sciences Ltd. | Supplier and customer | — |
| Strata Oncology, Inc. | Supplier and customer | — |
| Tempus Labs, Inc. | Supplier and customer | — |
| Takeda Pharmaceutical | Supplier and customer | — |
| SAMSUNG BIOLOGICS | Supplier and customer | — |
Similar companies
Companies in the same industry as Elevation Oncology LLC
Information on this page is provided for informational purposes only and is not a recommendation to buy, sell or hold any security. Investing involves risk, including possible loss of principal. Market data is delayed at least 15 minutes and is provided without warranty. Analyst ratings, price targets and company data come from third-party sources. Past performance does not guarantee future results.